We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

31 hedge funds and large institutions have $13.4M invested in ImmuCell in 2026 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

55% more capital invested

Capital invested by funds: $8.67M → $13.4M (+$4.73M)

15% more funds holding

Funds holding: 27 → 31 (+4)

0% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 7

0.4% less ownership

Funds ownership: 15.13% → 14.74% (-0.4%)

Holders
31
Holders Change
+4
Holders Change %
+14.81%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
7
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$170K
2
Jane Street
Jane Street
New York
+$139K
3
QC
Quadrature Capital
United Kingdom
+$136K
4
Morgan Stanley
Morgan Stanley
New York
+$108K
5
Mercer Global Advisors
Mercer Global Advisors
Colorado
+$106K

Top Sellers

Rank Fund Capital Flow
1
BL
Bleichroeder LP
New York
-$456K
2
Northern Trust
Northern Trust
Illinois
-$238K
3
SRC
Shufro Rose & Co
New York
-$221K
4
S
Steadtrust
Texas
-$79.5K
5
MCM
Militia Capital Management
Texas
-$70.7K

ICCC Hedge Fund Activity: Q2 2026 in Review

31 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q2 2026, worth a combined $13.4M — up 55% from $8.67M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new ICCC positions and 3 closed out — a net gain of 4 holders — while 7 added to existing stakes and 7 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $170K. The largest seller was Bleichroeder LP, cutting an estimated $456K.

  • 31 institutional investors held ImmuCell (ICCC) as of Q2 2026, up from 27 in Q1 2026.
  • Funds reported $13.4M of ImmuCell stock for Q2 2026, up 55% quarter-over-quarter.
  • 7 funds opened new ImmuCell positions in Q2 2026 and 3 closed out, a net change of +4 holders.
  • The largest ImmuCell buyer in Q2 2026 was Renaissance Technologies, an estimated $170K added.
  • The largest ImmuCell seller in Q2 2026 was Bleichroeder LP, an estimated $456K sold.

Based on aggregated 13F filings for Q2 2026.